attention to scientists, but do they know how to be heard? One simple way for scientists to contribute beyond university walls is to comment on proposed rules and guidelines within their area of expertise-be it the application of genomics to genetic tests or recombinant technology to genetically modified organisms (see Table 1 ; Box 1). Once federal agencies have listened to public opinion, they finalize rules and use them to clarify laws. For example, the National Institutes of Health (NIH) is currently requesting comments, before May 26, on draft guidelines that specify which embryonic stem cell lines will be eligible for federal funds. Once finalized, these guidelines will be used to evaluate research proposals to ensure that "NIH-funded research in this area is ethically responsible, scientifically worthy, and conducted in accordance with applicable law."
The process of posting a comment is straightforward. During the comment period-which typically lasts 30, 60, or 90 days-the public can go online (http://www. regulations.gov), access rules and guidelines as they are being drafted, and submit a comment before the rules are finalized. Once the period ends, a public meeting on the topic is often held. Federal agency officials then consider each written and oral comment and respond; their response is publicly available as well.
Public participation in the process that makes, applies, and amends US federal rules has been officially encouraged since 1946. In 2003, it went online. And by the end of this year, its accessibility will be enhanced due to President Obama's mandate to make the rulemaking process more transparent and democratic. Yet despite federal encouragement and the ease of posting a comment, scientists do not seem to be participating unless the proposals directly impact their research. "People whose research is affected probably look more carefully" at the Federal Register, says Harvard geneticist Daniel Hartl. "But people who are more peripherally associated tend to think that someone else should deal with it."
However, the result of translating scientific advances into products used by the general public-be it genetically engineered organisms, genetic tests, stem cell therapy, or gene therapy-will affect all researchers in the long run. When concerns arise about the safety of a particular method or product, society tends to question science in general. "The public must be able to trust the science and the scientific process informing public policy decisions," wrote President Obama in a memorandum on scientific integrity, published on March 9. In response to his memo, the Office of Science and Technology Policy posted a notice on the Federal Register asking for recommendations from the public before May 13 on how to ensure that the scientific information that agencies rely on is reliable.
Is Silence Golden?
Will scientists comment on the restrictions listed in the NIH's draft guidelines for federal funding of stem cell research? "I will comment however I can," says Irving Weissman, the director of the Stem Cell Biology and Regenerative Medicine Institute at Stanford University in Palo Alto, CA. "When you read the guidelines, the NIH says it will not use stem cells derived by [somatic cell] nuclear transfer," he says. "I hope they use this time of comments to rethink the issue of why they want to ban funding, especially when it might be the sole way to treat real human disease."
George Daley, the director of the stem cell transplantation program at Children's Hospital in Boston, has concerns about the eligibility of existing embryonic stem cell lines established from embryos whose donors chose to discard them but might not have been informed of alternative options required for consent today. "It's problematic to hold yesterday's cell lines to today's informed consent standards," Daley says. "Lines derived long ago by the highest standards of the time and with thoughtful informed consent should be 'grandfathered' into the new policy."
Another notice up for comment until May 15 poses questions about whether certain gene patenting and licensing practices may have adverse effects on the cost and quality of genetic tests and on patients' access to them. In part, this notice is a response to recent controversies about restrictive patents on disease genes such as the BRCA1 and BRCA2 genes associated with breast and ovarian cancer. Critics have argued that the
Will Scientists Cast Their Votes?
With science and technology high on the agenda of the new US administration, scientists should welcome the opportunity to influence policy. However, few academic scientists seem to be noticing proposals posted for public comment on the Federal Register that concern the application of science to society.
Box 1. Glossary
Regulations.gov: A website (http://www. regulations.gov) on which users can access all Federal Register documents open for comment across the Federal government. In addition, the public can find, view, and comment on additional rulemaking and non-rulemaking documents. Federal Register: The official daily publication for rules, proposed rules, and notices of Federal agencies and organizations, as well as executive orders and other presidential documents. Rulemaking: The process followed by Federal departments and agencies to formulate, amend, or repeal a regulation. Docket: A repository for all materials specifically referenced in the Federal Register document, any public comments received, and other information used by decisionmakers or otherwise related to rulemaking activity, such as supporting analyses. Comment: A written expression of an opinion or attitude by a member of the public to a government agency about a rulemaking or other action.
Source: Regulations.gov has circulated emails asking their members to prepare comments in response to the NIH stem cell guidelines so that they can submit a comment on behalf of the society.
Calling All Scientists
People affiliated with biotechnology companies and advocacy groups often flood the Federal Register with comments. For example, draft guidelines posted by the US Food and Drug Administration (FDA) regarding genetically engineered animals that produce drugs, vitamins, or other marketable traits received some 200 comments earlier this year; only a few were from scientists at academic institutions.
"It may be that the academic community is not familiar with the commenting process and did not understand that they could comment," says Larisa Rudenko, senior advisor for biotechnology at the FDA and the agency's point person for animal biotechnology. "We were hoping more academics would comment on the guidance" because their comments tend to be substantial and specific, she says.
Rules usually take years to finalize, in part because federal agencies do not want to downplay risks. Documents posted on the Federal Register often direct questions to scientists, soliciting advice on say, the mutability of certain gene constructs. Although the first FDA approved biopharm animals-goats producing anticoagulant drugs-were approved soon after the guidance was finalized, the FDA staff responsible for implementing the guidance can still be reached. "After every point [in the process], come in, comment, or call," Rudenko says. "You don't need to submit a package, just give us a call and we'll work with you." Rudenko says the last thing the FDA wants to do is frighten off academics by presenting themselves as bureaucratic or unresponsive.
Yet when asked what he knows about the Federal Register, Kristofor Langlais, a molecular geneticist at the NIH in Bethesda, MD, answers, "I don't know exactly what it is, but I've heard of it." He says that although he cannot speak for others, he can guess why scientists rarely get involved with policy. "Most science programs teach science…but neglect to include training in how science and society go together," he says. "My hunch is that scientists that never had a significant society aspect included in their training don't feel comfortable getting involved with these issues, because perhaps the mechanisms by which policy is developed and adapted are so foreign." "In all fairness, scientists working day to day are not going to read the Register unless someone prods them to comment," says Neil Holtzman, now a professor emeritus at Johns Hopkins School of Medicine and author of the 1989 book Proceed with Caution: Predicting Genetic Risks in the Recombinant DNA Era. But it is not a time issue, he says. Perhaps the issue is where their concerns lie. When the various scientific societies he belonged to sent him emails or letters asking that he comment on a federal proposal, he says these requests rarely involved public policy. "I got letters asking about expanding the budget [for research], but I seldom got a letter saying here's a policy that's harmful to the public, would you write a letter?"
Instead, Holtzman and a handful of other scientists influenced public policy on their own, by expressing their concerns about the Human Genome Project as it emerged in the early 1990s. Later, when Holtzman co-chaired the NIH-DOE Task Force on Genetic Testing, he helped to persuade the US Department of Health and Human Services to create a committee on genetic testing.
Read Regs, Run Gel, Post Comment Posting a comment may be less effective than testifying before Congress or serving on a federal task force like Holtzman did, but it is a way to strengthen the voice of science without impacting research productivity or teaching responsibilities. It took very little time for Bruce Tabashnik, an entomologist at the University of Arizona in Tucson, to compose his comment for the Register. "Were my two hours worth it?" he says, "Absolutely." Jeannette Martinez of the Environmental Protection Agency (EPA) had met Tabashnik at an entomology meeting and later asked him to post a comment on a model of insect resistance to an insecticide produced by transgenic corn. In his comment, Tabashnik enumerated reasons why he thought that the assumptions of the model, submitted by the company that produced the corn, were incorrect. The final decision has yet to be released, but Tabashnik says he is satisfied knowing that his letter triggered a debate over something that would have otherwise been regarded as fact.
Commenting does not pay and may not improve a CV, but according to Tabashnik, there are emotional benefits. He says, "I invest my life in developing knowledge in one area and I see it as rewarding to even expend the effort to have it be of some use to society."
